|
|
Volumn 36, Issue 3, 2015, Pages 479-480
|
|
Risk of neuroleptic malignant syndrome in patients with NMDAR encephalitis
a,b
|
|
Author keywords
Antipsychotics; Encephalitis; Neuroleptic malignant syndrome; Neuroleptics; Psychosis
|
|
Indexed keywords
ANTICONVULSIVE AGENT;
ATYPICAL ANTIPSYCHOTIC AGENT;
BENZODIAZEPINE DERIVATIVE;
NEUROLEPTIC AGENT;
RISPERIDONE;
ACUTE DISEASE;
AGITATION;
ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS;
AWARENESS;
CASE REPORT;
CATATONIA;
CLINICAL EVALUATION;
DIAGNOSTIC ERROR;
DIFFERENTIAL DIAGNOSIS;
DRUG MONITORING;
DRUG WITHDRAWAL;
EXTRAPYRAMIDAL SYMPTOM;
FAMILY HISTORY;
FEMALE;
HUMAN;
LETTER;
LOW DRUG DOSE;
MENTAL DISEASE;
NEUROLEPTIC MALIGNANT SYNDROME;
OUTCOME ASSESSMENT;
OVARY TUMOR;
PUERPERAL PSYCHOSIS;
ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS;
PATHOPHYSIOLOGY;
PUERPERIUM;
ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS;
DIAGNOSTIC ERRORS;
FEMALE;
HUMANS;
NEUROLEPTIC MALIGNANT SYNDROME;
POSTPARTUM PERIOD;
|
|
EID: 84925494718
PISSN: 15901874
EISSN: 15903478
Source Type: Journal
DOI: 10.1007/s10072-014-2022-z Document Type: Letter |
|
Times cited : (13)
|
|
References (5)
|
